Capitainer Expands Operations with Enhanced U.S. Presence
Capitainer, a leading Swedish MedTech company specializing in advanced self-sampling solutions, is pleased to announce the establishment of Capitainer Inc. in the United States. This expansion will enhance customer service and streamline order processing for the company’s growing U.S. market, further strengthening Capitainer’s goal to become the gold standard and global leader in self-sampling.
With the U.S. market expected to dominate Capitainer’s business within the next 1-3 years, this move solidifies Capitainer’s competitive edge in self-sampling across North America, reinforcing its position as the preferred choice for accurate and patient-centric sampling solutions.
Effective September 1, 2024, all U.S. orders will be processed through Capitainer Inc., enabling the company to provide faster, more tailored service to North American clients. Capitainer’s expanded U.S. presence will improve delivery times, offer local support, and allow for greater responsiveness to market needs.
“This expansion represents a significant milestone in our company's growth,” says Christopher Aulin, CEO of Capitainer. “By establishing a local presence in the U.S., we are strengthening our ability to provide exceptional service and support to our customers, ensuring that our innovative self-sampling solutions are accessible to more people. As the U.S. market grows to become central to our business, this first step will allow us to build a robust infrastructure to support our expansion.”
Capitainer Inc. will be headquartered in Providence, Rhode Island, focusing on customer support, order processing, and distribution. The U.S. market is Capitainer’s most important growth areas, and this expansion is the first key step in the company’s broader strategy to accelerate global growth and market reach, with a specific focus on North America.
“Establishing Capitainer Inc. is a strategic investment that aligns with our long-term goals of scaling up operations in key regions. This will allow us to better serve our existing customers while also positioning us to meet increasing demand for self-sampling solutions across North America,” says Kristina Thomsen Hall, CFO of Capitainer.
For more information, please contact:
Christopher Aulin, CEO
Phone: +46 (0)708 977577
Email: christopher.aulin@capitainer.com
About Capitainer
Capitainer AB is a Swedish MedTech company that develops and sells patient-centric solutions for self-sampling of blood, plasma, and urine. Founded in 2016, Capitainer has developed unique technologies for collecting and drying exact volumes of fluid within easy-to-use sampling cards. These cards may be sent as standard post to relevant testing laboratories, thus bypassing the need for cold chain logistics and specialised packaging. Capitainer’s products are market-leading with respect to precision and accuracy, with demonstrated equal performance to established pipetting methods. The products are applicable within several market segments, including but not limited to, clinical biomarkers, therapeutic drug monitoring, genomics, drug abuse and doping testing, and R&D and clinical studies.
Tags:
